[Morbidity during the XVI Central American and Caribbean Games: Puerto Rican delegation, Mexico 1990].

P R Health Sci J

Centro de Salud Deportiva y Ciencias del Ejercicio, Albergue Olímpico, Salinas PR 00751.

Published: September 1993

The health services offered to the Puerto Rican Delegation during the XVI Central American and Caribbean Sports Games in México in 1990 included: medical, dental and psychological assistance, physical therapy and services on the playing field. From the consultation sheets completed during the Games we obtained information about the use of these services. The 336 members of the Puerto Rico Delegation in the village at México City had 1,838 encounters with the health team. Of these, 991 were medical consults, 55 group therapies, 466 physical therapy sessions and 326 encounters in the sports venues. Among the encounters for medical evaluation the most frequent problems were athletic injuries (318; 32.1%), respiratory problems (240; 24.2%), gastrointestinal conditions (126; 12.7%) and dental services (119; 12.0%). The most frequent athletic injuries were first degree strains (83; 26.1%), tendinitis (56; 17.6%), contusions (42; 13.2%), myositis (40; 12.6%) and first degree sprains (28; 8.8%). The health problems found were diversed and in the majority of cases mild in character, which can be attend by adequately trained on sports health primary health professionals.

Download full-text PDF

Source

Publication Analysis

Top Keywords

xvi central
8
central american
8
american caribbean
8
puerto rican
8
rican delegation
8
physical therapy
8
athletic injuries
8
health
5
[morbidity xvi
4
caribbean games
4

Similar Publications

The Family Doctor in the "COVID-19 Era".

Healthcare (Basel)

December 2024

Internal Medicine I-Discipline of Medical Semiology I, Department V, Center of Advanced Research in Cardiology and Hemostasology, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.

The SARS-CoV-2 virus infection, the most severe pandemic in recent human history, found healthcare systems around the world more or less unprepared. Adjusting to this challenge involved changes in the daily routines of healthcare systems, as well as the patients, once again highlighting the importance of primary care (family physician or general practitioner). In the context of the COVID-19 pandemic, the family doctor in Romania played a crucial role in patient management, rapidly adapting to the changes and challenges imposed by the state of emergency.

View Article and Find Full Text PDF

Introduction: Lactate clearance(LC) is critical in managing critically ill patients. We hypothesized that treatment allocation with different vasoactive drugs or the presence of a pulmonary artery catheter (PAC) could affect the behavior of lactate dynamics and, ultimately, the mortality in AMI-CS.

Materials And Methods: In 651 patients with AMI-CS, we examined the relationship of LC time with clinical, laboratory, and CS-management variables.

View Article and Find Full Text PDF

WONOEP appraisal: Targeted therapy development for early onset epilepsies.

Epilepsia

November 2024

Saul R. Korey Department of Neurology, Isabelle Rapin Division of Child Neurology, Laboratory of Developmental Epilepsy, Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York, USA.

The early onset epilepsies encompass a heterogeneous group of disorders, some of which result in drug-resistant seizures, developmental delay, psychiatric comorbidities, and sudden death. Advancement in the widespread use of targeted gene panels as well as genome and exome sequencing has facilitated the identification of different causative genes in a subset of these patients. The ability to recognize the genetic basis of early onset epilepsies continues to improve, with de novo coding variants accounting for most of the genetic etiologies identified.

View Article and Find Full Text PDF

Hydroxychloroquine and Sjögren's disease: current evidences for its use.

Joint Bone Spine

October 2024

Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Col. Belisario Domínguez Sección XVI, CP 14080 Mexico City, Mexico. Electronic address:

About 25-50% of patients with primary Sjögren's disease (SjD) take hydroxychloroquine (HCQ). Although it is widely prescribed, and recommended in international guidelines, its use is mostly based on expert opinion and personal experience. Our aim was to provide a comprehensive overview of the pathogenic mechanisms of HCQ, the current clinical evidence for its use, and its safety in primary SjD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!